Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment
- 13 November 2020
- journal article
- research article
- Published by Springer Nature in The Protein Journal
- Vol. 39 (6) , 619-630
Abstract
Remdesivir was approved by the U.S.A. Food and Drug administration for emergency use to interfere with the replication of SARS CoV-2 virus (the agent that causes COVID-19) in adults and children hospitalized with severe disease. The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. This study compared their binding sites and suggests the crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19. We virtually screened 682 FDA-approved compounds, and the top 10 compounds were selected by analysis of docking scores, (G-score, D-score, and Chemscore) and visual analysis using a structure-based docking approach of NSP3 of SARS CoV-2 virus. All immunization approaches are based on the SARS-CoV-2 virus spike protein. A recent study reported that the D614G mutation in the SARS-CoV-2 virus spike protein reduces S1 shedding and increases infectivity of SARS COV-2 virus. Therefore, if there is a severe change in the spike protein of a modified Coronavirus, all developed vaccines can lose their efficacy, necessitating the need for an alternative treatment method. The top 10 compounds (FDA-approved) in this study are selected based on NSP 3 binding site, and therefore are a potential viable treatment because they will show potential activity for all mutations in the SARS-CoV-2 virus spike protein.Keywords
This publication has 26 references indexed in Scilit:
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- 5-Methyl-tetrahydrofolate in prevention of recurrent preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2015
- Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General ResultsJournal of Chemical Information and Modeling, 2014
- Determinants of Long-term Protection After Hepatitis B Vaccination in InfancyThe Pediatric Infectious Disease Journal, 2013
- Periconceptional multivitamin use and risk of preterm or small-for-gestational-age births in the Danish National Birth CohortThe American Journal of Clinical Nutrition, 2011
- Structural and Functional Basis for ADP-Ribose and Poly(ADP-Ribose) Binding by Viral Macro DomainsJournal of Virology, 2006
- General and targeted statistical potentials for protein–ligand interactionsProteins: Structure, Function, and Bioinformatics, 2005
- PMF Scoring RevisitedJournal of Medicinal Chemistry, 2005
- Virtual Docking Approaches to Protein Kinase B InhibitionJournal of Medicinal Chemistry, 2005
- Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search EngineJournal of Medicinal Chemistry, 2003